APH Form 4/A Corrects Trust Ownership; 76,400 Shares Disposed
Rhea-AI Filing Summary
Amended Form 4 for APH reporting correction to prior insider filing. The filing shows that on 08/18/2025 the reporting person disposed of 76,400 shares of Class A common stock. Following the reported transactions the reporting person beneficially owns 25,000 shares indirectly through a 2025 GRAT #1 and 0 shares indirectly through a 2024 Irrevocable Trust. The amendment states a previously filed Form 4 (filed 08/19/2025) incorrectly reported that the 2024 Irrevocable Trust beneficially owned non-derivative securities; this amendment corrects the beneficial ownership amounts. The form is signed by Lance E. D'Amico and identifies his role as Sr. VP, Secretary & General Counsel of Amphenol Corporation.
Positive
- Amendment filed to correct prior error, improving disclosure accuracy
- Post-transaction beneficial ownership clarified (25,000 shares held indirectly in 2025 GRAT #1)
Negative
- Insider disposed of 76,400 Class A shares on 08/18/2025 (sale reduces direct holdings)
- Prior Form 4 misreported beneficial ownership for the 2024 Irrevocable Trust, indicating a reporting lapse
Insights
TL;DR: Amendment corrects prior reporting and discloses an insider disposal of 76,400 shares; impact appears procedural and not immediately material to operations.
The amended Form 4 clarifies beneficial ownership after a sale on 08/18/2025 and removes an erroneous attribution to a 2024 Irrevocable Trust. The direct disposal of 76,400 Class A shares reduces the reporting person's direct stake; however, without price or percentage of outstanding shares the market-cap impact cannot be assessed from this filing alone. The correction improves disclosure accuracy, which is important for governance and market transparency.
TL;DR: Correction indicates a prior reporting error; filing the amendment is a positive compliance step but highlights a lapse in initial reporting accuracy.
The amendment explicitly states the initial Form 4 misattributed non-derivative holdings to the 2024 Irrevocable Trust and now provides the corrected post-transaction ownership figures. Timely amendment reduces regulatory risk, but the initial misstatement is a governance concern that investors monitoring insider reporting practices may note. No new derivative instruments or compensatory grants are disclosed.